-
公开(公告)号:JP2010270135A
公开(公告)日:2010-12-02
申请号:JP2010164769
申请日:2010-07-22
Applicant: Abbott Lab , アボット・ラボラトリーズAbbott Laboratories
Inventor: BAUER JOHN F , SALEKI-GERHARDT AZITA , NARAYANAN BIKSHANDARKOIL A , CHEMBURKAR SANJAY R , PATEL KETAN , SPIWEK HARRY O , BAUER PHILIP E , ALLEN KIMBERLY A
IPC: C07D277/28 , A61K31/426 , A61K31/427 , A61P31/18 , A61P37/04 , C07D277/24 , C07D277/30 , C07D277/36 , C07D277/40 , C07D277/42 , C07D417/12
CPC classification number: C07D277/28
Abstract: PROBLEM TO BE SOLVED: To provide a novel crystalline polymorphous form of ritonavir and a process for producing the same.
SOLUTION: There is provided a substantially pure crystalline polymorphous form of (2S, 3S, 5S)-5-(N-(N-((N-methyl-N-((2-isopropyl-4-thiazoyl)methyl)amino)carbonyl)-L-valinyl)amino)-2-(N-((5-thiazolyl)methoxycarbonyl)amino)-1,6-diphenyl-3-hydroxyhexane which gives peaks of 2θ angle at 8.67°±0.1°, 9.88°±0.1°, 16.11°±0.1°, 16.70°±0.1°, 17.36°±0.1°, 17.78°±0.1°, 18.40°±0.1°, 18.93°±0.1°, 20.07°±0.1°, 20.65°±0.1°, 21.71°±0.1° and 25.38°±0.1° in a powder X-ray diffraction pattern. There is also provided a process for producing the crystalline polymorph form, which includes inoculating seed crystals in a solution of ritonavir, and then adding an anti-solvent.
COPYRIGHT: (C)2011,JPO&INPITAbstract translation: 待解决的问题:提供新型的晶体多晶形式的利托那韦及其制备方法。 提供了(2S,3S,5S)-5-(N-(N - ((N-甲基-N - ((2-异丙基-4-噻唑基)甲基) )氨基)羰基)-L-缬氨酰基)氨基)-2-(N - ((5-噻唑基)甲氧基羰基)氨基)-1,6-二苯基-3-羟基己烷,其在8.67°±0.1°处产生2θ角的峰 ,9.88°±0.1°,16.11°±0.1°,16.70°±0.1°,17.36°±0.1°,17.78°±0.1°,18.40°±0.1°,18.93°±0.1°,20.07°±0.1°,20.65° 在粉末X射线衍射图中为±0.1°,21.71°±0.1°和25.38°±0.1°。 还提供了一种制备结晶多晶型形式的方法,其包括将晶种接种在利托那韦的溶液中,然后加入抗溶剂。 版权所有(C)2011,JPO&INPIT
-
公开(公告)号:WO0004016A3
公开(公告)日:2000-03-30
申请号:PCT/US9916334
申请日:1999-07-19
Applicant: ABBOTT LAB
Inventor: BAUER JOHN F , SALEKI-GERHARDT AZITA , NARAYANAN BIKSHANDARKOIL A , CHEMBURKAR SANJAY R , PATEL KETAN , SPIWEK HARRY O , BAUER PHILIP E , ALLEN KIMBERLY A
IPC: A61K31/426 , A61K31/427 , A61P31/18 , A61P37/04 , C07D277/24 , C07D277/28 , C07D277/30 , C07D277/36 , C07D277/40 , C07D277/42 , C07D417/12 , A61K31/425
CPC classification number: C07D277/28
Abstract: A new crystalline polymorph of ritonavir and methods for its use and preparation are disclosed.
Abstract translation: 公开了利托那韦的新结晶多晶型物及其使用和制备方法。
-
公开(公告)号:SK287381B6
公开(公告)日:2010-08-09
申请号:SK50292008
申请日:1999-07-19
Applicant: ABBOTT LAB
Inventor: BAUER JOHN F , SALEKI-GERHARDT AZITA , NARAYANAN BIKSHANDARKOIL A , CHEMBURKAR SANJAY R , PATEL KETAN , SPIWEK HARRY O , BAUER PHILIP E , ALLEN KIMBERLY A
IPC: A61K31/00 , A61K31/426 , A61K31/427 , A61P31/18 , A61P37/04 , C07D277/00 , C07D277/24 , C07D277/28 , C07D277/30 , C07D277/36 , C07D277/40 , C07D277/42 , C07D417/12
Abstract: Amorphous ritonavir containing no more than 10 % of any other form of ritonavir characterised by the DSC thermogram recorded at a heating rate of 5 °C/min. and a glass transition temperature from about 45 °C to about 49 °C. Described is also a method for the preparation of amorphous ritonavir and its use.
-
公开(公告)号:DK1418174T3
公开(公告)日:2009-05-18
申请号:DK03029709
申请日:1999-07-19
Applicant: ABBOTT LAB
Inventor: BAUER JOHN F , SALEKI-GERHARDT AZITA , PATEL KETAN , CHEMBURKAR SANJAY R , SPIWEK HARRY O
IPC: C07D277/24 , A61K31/425 , A61K31/426 , A61K31/427 , A61P31/18 , A61P37/04 , C07D277/28 , C07D277/30 , C07D277/36 , C07D277/40 , C07D277/42 , C07D417/12
Abstract: This Application concerns the use of Form II crystalline ritonavir as a pharmaceutical agent, as well as methods of preparing pharmaceutical compositions, which methods employ Form II crystalline ritonavir. The Application further concerns methods for obtaining Form I crystalline ritonavir, which methods employ Form II crystalline ritonavir.
-
公开(公告)号:AU2007202943A1
公开(公告)日:2007-07-19
申请号:AU2007202943
申请日:2007-06-26
Applicant: ABBOTT LAB
Inventor: BAUER PHILIP E , ALLEN KIMBERLY A , NARAYANAN BIKSHANDARKOIL A , CHEMBURKAR SANJAY R , SALEKI-GERHARDT AZITA , SPIWEK HARRY O , BAUER JOHN F , PATEL KETAN
IPC: C07D417/00
-
公开(公告)号:PE00982003A1
公开(公告)日:2003-02-12
申请号:PE0004362002
申请日:2002-05-24
Applicant: ABBOTT LAB
Inventor: BARBATO ALESSANDRO , PETRICONI SERGIO , URCH MARTIN , SCUPPA ROBERTA , SALEKI-GERHARDT AZITA
IPC: A61K9/48 , A61K31/426 , A61K31/427 , A61K31/513 , A61K47/10 , A61K47/12 , A61K47/34 , A61P31/18
CPC classification number: A61K31/513 , A61K9/4858 , A61K31/427 , A61K2300/00
Abstract: LA CAPSULA COMPRENDE: I)UN RELLENO, QUE A SU VEZ CONTIENE: i)UN AGENTE O COMBINACION DE AGENTES FARMACEUTICOS, TAL COMO UN INHIBIDOR DE VIH SOLUBILIZADO QUE ES (2S,3S,5S)-5-(N-(N-((N-metil-N-N-((2-isopropil-4-tiazolil)-metil)amino)carbonil)-L-valinil)amino-2-(N-((5-tiazolil)metoxi-carbonil)-amino-1,6-difenil-3-hidroxihexano(ritonavir); ii)UN ALCOHOL; Y, iii)UN ACIDO GRASO; Y II)UN REVESTIMIENTO, QUE A SU VEZ COMPRENDE: 1)GELATINA; Y, 2)POR LO MENOS UN AGENTE PLASTIFICANTE. DONDE (II) TIENE UN ESTADO INICIAL Y UN ESTADO DE EQUILIBRIO; DE MANERA QUE EN EL ESTADO INICIAL SE SUBPLASTIFICA Y (I) CONTIENE UNA CANTIDAD EN EXCESO DE ALCOHOL RESPECTO DE LA CANTIDAD NECESARIA PARA SOLUBILIZAR EL AGENTE FARMACEUTICO Y DICHO ALCOHOL NO ESTA PRESENTE EN EL ESTADO INICIAL DE LA COMPOSICION DE REVESTIMIENTO, Y EN EL ESTADO DE EQUILIBRIO SE PLASTIFICA EL REVESTIMIENTO MEDIANTE EL ALCOHOL PROVENIENTE DEL RELLENO PARA PROPORCIONAR UNA DUREZA DE CAPSULA APROPIADA Y EL RELLENO RETIENE SUFICIENTE ALCOHOL COMO PARA MANTENER AL AGENTE FARMACEUTICO EN SOLUCION
-
公开(公告)号:CA2448438A1
公开(公告)日:2002-12-05
申请号:CA2448438
申请日:2002-05-21
Applicant: ABBOTT LAB
Inventor: PETRICONI SERGIO , BARBATO ALESSANDRO , URCH MARTIN , SALEKI-GERHARDT AZITA , SCUPPA ROBERTA
IPC: A61K9/48 , A61K31/426 , A61K31/427 , A61K31/513 , A61K47/10 , A61K47/12 , A61K47/34 , A61P31/18
Abstract: A soft elastic capsule is described containing a pharmaceutical agent or a mixture of pharmaceutical agents. The soft elastic capsule is prepared from a fill composition and a shell composition that impart acceptable physical characteristics to the soft elastic capsule when in an equilibrium state. Th e pharmaceutical agents of the fill composition are also soluble when the soft elastic capsule is in the equilibrium state.
-
公开(公告)号:TR200100171T2
公开(公告)日:2001-05-21
申请号:TR200100171
申请日:1999-07-19
Applicant: ABBOTT LAB
Inventor: BAUER JOHN F , SALEKI-GERHARDT AZITA , NARAYANAN BIKSHANDARKOIL A , CHEMBURKAR SANJAY R , PATEL KETAN , SPIWEK HARRY O , BAUER PHILIP E , ALLEN KIMBERLY A
IPC: A61K31/426 , A61K31/427 , A61P31/18 , A61P37/04 , C07D277/24 , C07D277/28 , C07D277/30 , C07D277/36 , C07D277/40 , C07D277/42 , C07D417/12 , A61K31/425
Abstract: This Application concerns the use of Form II crystalline ritonavir as a pharmaceutical agent, as well as methods of preparing pharmaceutical compositions, which methods employ Form II crystalline ritonavir. The Application further concerns methods for obtaining Form I crystalline ritonavir, which methods employ Form II crystalline ritonavir.
-
公开(公告)号:AU706837B2
公开(公告)日:1999-06-24
申请号:AU7517696
申请日:1996-10-18
Applicant: ABBOTT LAB
Inventor: SALEKI-GERHARDT AZITA , KESKE ERNEST R
IPC: A61K9/16 , A61K31/70 , A61K31/7042 , A61K31/7048 , A61K47/32
Abstract: The present invention provides a process for the aqueous granulation of a macrolide antibiotic which comprises mixing a macrolide antibiotic and a carbomer; wetting the mixture with water; and blending the mixture to allow formation of a macrolide antibiotic-carbomer granule.
-
公开(公告)号:MY145265A
公开(公告)日:2012-01-13
申请号:MYPI0402546
申请日:1999-07-16
Applicant: ABBOTT LAB
Inventor: BAUER JOHN F , SALEKI-GERHARDT AZITA , NARAYANAN BIKSHANDARKOR A , CHEMBURKAR SANJAY R , PATEL KETAN M , SPIWEK HARRY O , BAUER PHILIP E , ALLEN KIMBERLY A
IPC: A61K31/426 , A61K31/427 , A61P31/18 , A61P37/04 , C07D277/24 , C07D277/28 , C07D277/30 , C07D277/36 , C07D277/40 , C07D277/42 , C07D417/12
Abstract: SUBSTANTIALLY PURE AMORPHOUS RITONAVIR IS DISCLOSED. ALSO DISCLOSED A PROCESS FOR THE PREPARATION OF SUBSTANTIALLY PURE RITANOVIR CRYSTALLINE POLYMORPH FORM I COMPRISING ADDING A SOLUTION OF RITONAVIR TO A SLURRY OF SEED CRYSTALS OF RITONAVIR CRYSTALLINE POLYMORPH FORM I IN AN ANTI-SOLVENT.
-
-
-
-
-
-
-
-
-